Sabra Health Care REIT, Inc.

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

SBRA$21.47+2.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Equity

Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, June 30, 2024	234,262,497	$2,343	$4,536,645	$(1,808,158)	$31,145	$2,761,975	$—	$2,761,975
Net income	—	—	—	29,788	—	29,788	—	29,788
Other comprehensive loss	—	—	—	—	(14,206)	(14,206)	—	(14,206)
Amortization of stock-based compensation	—	—	3,104	—	—	3,104	—	3,104
Common stock issuance, net	2,324,308	23	34,958	—	—	34,981	—	34,981
Common dividends ($0.30 per share)	—	—	—	(70,798)	—	(70,798)	—	(70,798)
Balance, September 30, 2024	236,586,805	$2,366	$4,574,707	$(1,849,168)	$16,939	$2,744,844	$—	$2,744,844
Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Loss · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, June 30, 2025	239,792,173	$2,398	$4,625,050	$(1,913,932)	$(2,031)	$2,711,485	$—	$2,711,485
Net income (loss)	—	—	—	22,538	—	22,538	(21)	22,517
Other comprehensive loss	—	—	—	—	(3,945)	(3,945)	—	(3,945)
Contribution from noncontrolling interests	—	—	—	—	—	—	2,040	2,040
Amortization of stock-based compensation	—	—	3,879	—	—	3,879	—	3,879
Common stock issuance, net	9,557,500	95	163,824	—	—	163,919	—	163,919
Common dividends ($0.30 per share)	—	—	—	(72,942)	—	(72,942)	—	(72,942)
Balance, September 30, 2025	249,349,673	$2,493	$4,792,753	$(1,964,336)	$(5,976)	$2,824,934	$2,019	$2,826,953

CONSOLIDATED STATEMENTS OF EQUITY (CONTINUED)

Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, December 31, 2023	231,266,020	$2,313	$4,494,755	$(1,718,279)	$23,745	$2,802,534	$—	$2,802,534
Net income	—	—	—	80,017	—	80,017	—	80,017
Other comprehensive loss	—	—	—	—	(6,806)	(6,806)	—	(6,806)
Amortization of stock-based compensation	—	—	8,180	—	—	8,180	—	8,180
Common stock issuance, net	5,320,785	53	71,772	—	—	71,825	—	71,825
Common dividends ($0.90 per share)	—	—	—	(210,906)	—	(210,906)	—	(210,906)
Balance, September 30, 2024	236,586,805	$2,366	$4,574,707	$(1,849,168)	$16,939	$2,744,844	$—	$2,744,844
Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, December 31, 2024	237,586,882	$2,376	$4,592,605	$(1,874,633)	$20,940	$2,741,288	$—	$2,741,288
Net income (loss)	—	—	—	128,384	—	128,384	(21)	128,363
Other comprehensive loss	—	—	—	—	(26,916)	(26,916)	—	(26,916)
Contribution from noncontrolling interests	—	—	—	—	—	—	2,040	2,040
Amortization of stock-based compensation	—	—	11,685	—	—	11,685	—	11,685
Common stock issuance, net	11,762,791	117	188,463	—	—	188,580	—	188,580
Common dividends ($0.90 per share)	—	—	—	(218,087)	—	(218,087)	—	(218,087)
Balance, September 30, 2025	249,349,673	$2,493	$4,792,753	$(1,964,336)	$(5,976)	$2,824,934	$2,019	$2,826,953

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.